Literature DB >> 25957470

[Renal involvement in glycogen storage disease type 1: Practical issues].

Amel Ben Chehida1, Takoua Bensmaïl2, Faten Ben Rehouma3, Rim Ben Abdelaziz2, Hatem Azzouz2, Hela Boudabbous2, Mohamed Slim Abdelmoula2, Sonia Abdelhak3, Naziha Kaabachi4, Hadhami Ben Turkia2, Néji Tebib2.   

Abstract

AIM: To investigate risk factors of renal complications in glycogen storage disease type I, in order to identify practical implications for renal preservation.
METHODS: A retrospective study of 38 patients with glycogen storage disease type I.
RESULTS: The patients studied were 8.6 years old in average (1.5 to 22 years) and were followed during 7.4 ± 4.5 years. Hypercalciuria was detected in 23 patients and was related to acidosis (P=0.028), higher lactate levels (5.9 ± 3.5 versus 3.7 ± 1.7 mmol/L; P=0.013) and smaller height (-2.1 ± 1.5 SD versus -0.8 ± 1.5 SD; P=0.026). Urolithiasis was diagnosed in 7 cases. Glomerular disease (19/38) was more frequent in cases with severe hypertriglyceridemia (P=0.042) and occurred at an older age (P=0.007). Microalbuminuria occurred in 15/31 cases; ACE inhibitors were prescribed in only 8 cases. The frequency of renal complications did not differ according to the diet group (continuous enteral feeding or uncooked starch). Logistic regression concluded as risk factors: lactic acidosis for tubular disease and age>10 years for glomerular disease.
CONCLUSIONS: Renal involvement is common in glycogen storage disease type I patients. Tubular abnormalities are precocious, related to lactic acidosis and may be detected by monitoring of urinary calcium. Glomerular hyperfiltration is the first stage of a progressive glomerular disease and is related to age. Practical implications for renal preservation are discussed based on our results and literature.
Copyright © 2015 Association Société de néphrologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Acidose lactique; Angiotensin-converting enzyme inhibitors; Glycogen storage disease type I; Glycogénose de type I; Hypertriglyceridemia; Hypertriglycéridémie; Inhibiteurs de l’enzyme de conversion de l’angiotensine; Kidney diseases; Lactic acidosis; Maladies du rein; Urolithiases; Urolithiasis

Mesh:

Year:  2015        PMID: 25957470     DOI: 10.1016/j.nephro.2014.12.007

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  1 in total

1.  Successful Treatment of Refractory Anemia in a Patient With Glycogen Storage Disease Type Ia Undergoing Hemodialysis.

Authors:  Hirotaka Sato; Kentaro Takase; Seikon Kin
Journal:  Cureus       Date:  2022-06-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.